Changes in the level of NT-proBNP in our study correlated with greater changes in the effective area of the regurgitation orifice (as a criterion for assessing mitral regurgitation), LVEF, and size of the LV and left atrium of the group taking sacubitril/valsartan compared to the valsartan group. This evidence concerns the gene NPPB and Mitral regurgitation.